Is Obinutuzumab the Answer to Primary Membranous Nephropathy Resistant to Rituximab? [PDF]
Giri K, Glassock RJ, Fervenza FC.
europepmc +1 more source
Antidiabetic Effect of Tiger Nut and Coconut Blend in Experimental Type 2 Diabetic Rat Model
The combination of tiger nut and coconut demonstrated antihyperglycemic, antihyperlipidemic, anti‐inflammatory, and antioxidant activities on type 2 diabetic rat model over a 4‐week treatment period. ABSTRACT Tiger nut and coconut are chewy and popularly consumed as food either alone, mixed, or paired with other fruits, seeds, and vegetables.
Aminu Mohammed, Mubarak Labaran Liman
wiley +1 more source
Retrospective study of treatment effectiveness and remission predictors of obinutuzumab in primary membranous nephropathy. [PDF]
Jiang Z +5 more
europepmc +1 more source
ABSTRACT Pathological cardiac hypertrophy is initially an adaptive response to sustained mechanical, neurohormonal, or metabolic stress; however, it can progress to fibrosis, contractile dysfunction, arrhythmia, and heart failure. Ferroptosis is a type of regulated cell death caused by iron‐dependent phospholipid peroxidation.
Pengbo Liu, Yongzhi Deng
wiley +1 more source
Efficacy and safety of different immunosuppressive agents in patients with calcineurin inhibitor-dependent primary membranous nephropathy. [PDF]
Li Z, Cao S, Liang Z, Zhao F, Li K.
europepmc +1 more source
ABSTRACT Given the widespread reliance on insulin among diabetic patients, ensuring its stability is an essential task not only for preserving its therapeutic efficacy but also for safeguarding patient health and safety. In addition, insulin storage practices were frequently misunderstood that may compromise drug potency.
Majdi Ben Messaoud +7 more
wiley +1 more source
Efficacy and safety of obinutuzumab in patients with primary membranous nephropathy: a focus on refractory and rituximab-resistant patients. [PDF]
Gao Q, Yao G, Sun Y, Li X, Li Z, Chen B.
europepmc +1 more source
Conventional clinical trials remain the benchmark for evaluating therapeutic safety and efficacy, yet they are constrained by escalating costs, withdrawal over the extended follow‐up periods, recruitment difficulties, ethical limits, and a restricted ability to characterize heterogeneous populations.
Maximilian Balmus +7 more
wiley +1 more source
Proteinuria selectivity index as a predictor of remission and rituximab efficacy in primary membranous nephropathy: a single-center retrospective analysis. [PDF]
Li H, Zhang Y, Ding X, Zhang C.
europepmc +1 more source
In diabetic kidney disease, one urine specimen carries shed cells, extracellular vesicles and cell‐free DNA released along the whole nephron. Reading all three against spatial kidney atlases is proposed as a testable route to cell‐resolved, non‐invasive risk stratification, and the clinical outputs shown are not yet demonstrated.
Juan Wu, Ping Sheng, Ying Lu, Ke Chen
wiley +1 more source

